Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
NCT ID: NCT01434797
Last Updated: 2020-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11 participants
OBSERVATIONAL
2011-09-30
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT
NCT04437927
PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
NCT03429387
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
NCT01432002
PET Imaging in Patients at Risk for Acute Lung Injury
NCT01486342
Siderophores for Imaging Infection Using 68Ga-DFO
NCT05285072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Confirmed CVCP infection before removal
Patients with permanent central venous catheter infection confirmed by conventional method
No interventions assigned to this group
Presumed CPVP infection before removal
Patients with probable permanent central venous catheter infection (standard methods for infection detection not conclusive)
No interventions assigned to this group
Uninfected CVCP before removal
Patients with planned permanent central venous catheter removal (no infection)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with probable catheter infection requiring surgical removal
* patients with planned removal of uninfected catheter
* ≥18years old
Exclusion Criteria
* pregnancy and breastfeeding
* severe septicemia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John O. Prior
Centre Hospitalier Universitaire Vaudois, Nuclear Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John O Prior, PhD MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Vaudois and University of Lausanne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire Vaudois, Nuclear Medicine
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
89/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.